Home/Filings/4/0000950170-23-068312
4//SEC Filing

WIINBERG ULF 4

Accession 0000950170-23-068312

CIK 0001840229other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 6:05 PM ET

Size

5.5 KB

Accession

0000950170-23-068312

Insider Transaction Report

Form 4
Period: 2023-12-01
WIINBERG ULF
Director
Transactions
  • Award

    Common Stock

    2023-12-01$1.04/sh+14,424$15,00174,543 total
Holdings
  • Common Stock

    (indirect: See footnote)
    278,300
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
  • [F2]Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.

Documents

1 file

Issuer

MiNK Therapeutics, Inc.

CIK 0001840229

Entity typeother

Related Parties

1
  • filerCIK 0001187314

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 6:05 PM ET
Size
5.5 KB